© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to November
reversible ATX inhibitor w/ alt. binding mode
in vivo PD observed on oral dosing
from HTS screen and opt.
Bioorg. Med. Chem. Lett., Nov. 4, 2020
Novartis, Horsham, UK / Basel, CH
“compound 15a” (Novartis reversible in vivo ATX inhibitor)
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.